Posts

Podnosis Episode: The Push to Expand Access to Emergency Contraception

on
Podnosis podcast episode from April 29, 2026, discusses efforts to expand access to emergency contraception beyond pharmacies. Cadence OTC sells a cheaper morning-after pill alternative to Plan B and pursues distribution through convenience stores and gas stations to address pharmacy deserts. Company advocates for over-the-counter availability of a daily birth control pill. Features interview with Cadence OTC co-founder and CEO Samantha Miller on reshaping reproductive healthcare and policy challenges. Hosted by Senior Writer Anastassia Gliadkovskaya from Fierce Healthcare. Sources:

No Recent News Found on Samsung Biologics' $102M Strike Impact

on

The NewCo Model in Chinese Biotech: A Transformative Exit Strategy for Global Expansion

on

FDA Action Alert: Upcoming Decisions on Argenx, AstraZeneca/Daiichi Sankyo, Biogen/Eisai, and Cingulate

on

Zealand Pharma Board Proposes Election of Camilla Sylvest to Board of Directors

on

Axsome's Auvelity Gains FDA Approval as First Non-Antipsychotic for Alzheimer's Agitation, Challenging Rexulti

on

Medicines Australia Announces Four New Board Directors on 1 May 2026

on

Evolving Lymphoma Market Sidelines Two J&J CAR-T Programmes

on

Hemab and Seaport Post Gains on NASDAQ After Raising $550M Across Their Debuts

on

FDA Approves Arvinas and Pfizer's Veppanu (vepdegestrant), First PROTAC for ESR1-Mutated Breast Cancer

on

Outfront Health Appoints Dr. Shane Speirs as Chief Medical Officer

on

E-Scopics Announces New FDA Clearance for Hepatoscope® With Expanded Capabilities in Managing Liver Disease Complications, Advanced Elastography Imaging Features, and Improved Compatibility to Be Presented at DDW 2026

on

Esperion Therapeutics Acquired by Archimed in $1.1B Buyout Deal

on